Investing
Today's Best Market Rumors (7/16/2012) GlaxoSmithKline Buys Human Genome Sciences
July 16, 2012 8:59 am
Updated throughout the day on the 24/7 Wall St. Wire:
GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters)
The Justic Department and HSBC (NYSE: HBC) are close to a settlement on money laundering for drug cartel charges. (WSJ)
Douglas A. McIntyre
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Editors' Picks
